JCVI: Prediction of Anticancer Molecules Using Hybrid Model Developed on Molecules Screened Against NCI-60 Cancer Cell Lines.
 
 
Section Banner

Publications

Citation

Singh H, Kumar R, Singh S, Chaudhary K, Gautam A, Raghava GP

Prediction of Anticancer Molecules Using Hybrid Model Developed on Molecules Screened Against NCI-60 Cancer Cell Lines.

BMC Cancer. 2015 Mar 01; 16: 77.

External Citation

Abstract

In past, numerous quantitative structure-activity relationship (QSAR) based models have been developed for predicting anticancer activity for a specific class of molecules against different cancer drug targets. In contrast, limited attempt have been made to predict the anticancer activity of a diverse class of chemicals against a wide variety of cancer cell lines. In this study, we described a hybrid method developed on thousands of anticancer and non-anticancer molecules tested against National Cancer Institute (NCI) 60 cancer cell lines.

This publication is listed for reference purposes only. It may be included to present a more complete view of a JCVI employee's body of work, or as a reference to a JCVI sponsored project.